Antibodies Targeting K V Potassium Channels: A Promising Treatment for Cancer
Authors:
- 1 September 2019
- journal article
- research article
- Published by SAGE Publications in Bioelectricity
- Vol. 1 (3) , 180-187
Abstract
Voltage-gated potassium channels are transmembrane proteins that allow flow of potassium across the membrane to regulate ion homeostasis, cell proliferation, migration, cell volume, and specific processes such as muscular contraction. Aberrant function or expression of potassium channels can underlie pathologies ranging from heart arrhythmia to cancer; the expression of potassium channels is altered in many types of cancer and that alteration correlates with malignancy and poor prognosis. Targeting potassium channels therefore constitutes a promising approach for cancer therapy. In this review, we discuss strategies to target a particular family of potassium channels, the voltage-gated potassium channels (KV) where a reasonable structural understanding is available. We also discuss the possible obstacles and advantages of such a strategy.Keywords
This publication has 93 references indexed in Scilit:
- Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsGenes & Development, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibodyMolecular Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary HypertensionScience, 2011
- The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemiaMolecular Cancer, 2010
- Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosusCell Calcium, 2010
- Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery, 2009
- Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in TumorsJournal of Biological Chemistry, 2008
- Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytesProceedings of the National Academy of Sciences of the United States of America, 2008